Analysis of diagnostic pathway and therapeutic delay for patients with pancreatic adenocarcinoma: a French retrospective study
Therapeutic Advances in Gastroenterology
Published online on March 11, 2026
Abstract
Therapeutic Advances in Gastroenterology, Volume 19, January-December 2026.
Background:Pancreatic adenocarcinoma (PA) is a growing public health concern and is expected to become the second leading cause of cancer-related death in Europe by 2030. Despite therapeutic advances, prognosis remains poor, with stage at diagnosis the ...
Background:Pancreatic adenocarcinoma (PA) is a growing public health concern and is expected to become the second leading cause of cancer-related death in Europe by 2030. Despite therapeutic advances, prognosis remains poor, with stage at diagnosis the ...